Literature DB >> 12461416

Association between cervical shedding of herpes simplex virus and HIV-1.

R Scott McClelland1, Chia C Wang, Julie Overbaugh, Barbra A Richardson, Lawrence Corey, Rhoda L Ashley, Kishorchandra Mandaliya, Jeckoniah Ndinya-Achola, Job J Bwayo, Joan K Kreiss.   

Abstract

OBJECTIVE: To investigate the association between the cervical shedding of herpes simplex virus (HSV) and HIV-1.
DESIGN: A cross-sectional study on 200 women seropositive for both HSV-2 and HIV-1 was conducted in a family planning clinic at the Coast Provincial General Hospital, Mombasa, Kenya. MAIN OUTCOME MEASURES: Quantities of HSV DNA (types 1 and 2) and HIV-1 RNA as well as the presence or absence of HIV-1 proviral DNA in cervical secretions were determined and compared.
RESULTS: There was a significant correlation between the quantities of HSV DNA and HIV-1 RNA in the cervical secretions of HSV-shedding women (Pearson's r = 0.24, P = 0.05). A 10-fold increase in the quantity of cervical HSV DNA was associated with 1.35-fold higher cervical HIV-1-RNA levels (95% CI 1.00-1.81; P = 0.05), and with 1.36-fold greater odds of detection of HIV-1 proviral DNA (95% CI 1.05-1.75; P = 0.02).
CONCLUSION: Higher levels of cervical HSV were associated with higher levels of expressed HIV-1 and with the more frequent detection of HIV-1-infected cells in cervical secretions. Prospective studies are needed to explore further the association between non-ulcerative cervical HSV reactivation and HIV-1 shedding. Such a relationship may have important implications for interventions designed to slow the spread of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461416     DOI: 10.1097/00002030-200212060-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  52 in total

1.  Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

Authors:  Alison L Drake; Alison C Roxby; Francisca Ongecha-Owuor; James Kiarie; Grace John-Stewart; Anna Wald; Barbra A Richardson; Jane Hitti; Julie Overbaugh; Sandra Emery; Carey Farquhar
Journal:  J Infect Dis       Date:  2011-12-06       Impact factor: 5.226

2.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

3.  Efforts to Control Sexually Transmitted Infections As a Means to Limit HIV Transmission: What Is the Evidence?

Authors:  Gina Dallabetta; Graham Neilsen
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

Review 4.  Efforts to control sexually transmitted infections as a means to limit HIV transmission: what is the evidence?

Authors:  Gina Dallabetta; Graham Neilson
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

5.  Determinants of HIV shedding in the lower genital tract of women.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

Review 6.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

7.  Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.

Authors:  Anna Gibbs; Taha Hirbod; Qingsheng Li; Karin Bohman; Terry B Ball; Francis A Plummer; Rupert Kaul; Joshua Kimani; Kristina Broliden; Annelie Tjernlund
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

8.  New insights on interactions between HIV-1 and HSV-2.

Authors:  Sinéad Delany-Moretlwe; Jairam R Lingappa; Connie Celum
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

9.  Can we reduce the spread of HIV infection by suppressing herpes simplex virus type 2 infection?

Authors:  Anne Buvé
Journal:  F1000 Med Rep       Date:  2010-06-16

10.  Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa.

Authors:  R G White; E E Freeman; K K Orroth; R Bakker; H A Weiss; N O'Farrell; A Buvé; R J Hayes; J R Glynn
Journal:  Sex Transm Infect       Date:  2008-10       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.